法国巴黎地区三家医疗中心的非专利抗逆转录病毒药物处方。

IF 3.4 2区医学 Q3 IMMUNOLOGY

AIDS Pub Date : 2024-07-01 Epub Date: 2024-05-30 DOI:10.1097/QAD.0000000000003899

Pierre Leroy, Sylvain Diamantis, Pierre-Olivier Sellier, Gwenn Hamet, Alexandre Brun, Willy Rozenbaum, Jean-Michel Molina

{"title":"法国巴黎地区三家医疗中心的非专利抗逆转录病毒药物处方。","authors":"Pierre Leroy, Sylvain Diamantis, Pierre-Olivier Sellier, Gwenn Hamet, Alexandre Brun, Willy Rozenbaum, Jean-Michel Molina","doi":"10.1097/QAD.0000000000003899","DOIUrl":null,"url":null,"abstract":"In a retrospective study conducted in three hospitals in Paris, generic antiretroviral accounted for 30.2% of all prescriptions. Tenofovir disoproxil/emtricitabine (TDF/FTC) was the most prescribed generic ART (82.3% of generic prescriptions). Generic ART (gART) was more likely to be prescribed to women, to patients less than 50 years, and with recent HIV diagnosis less than 3 years. Physicians prescribed more gART if they were men, older than 55 years or worked at a university teaching hospital.","PeriodicalId":7502,"journal":{"name":"AIDS","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France.\",\"authors\":\"Pierre Leroy, Sylvain Diamantis, Pierre-Olivier Sellier, Gwenn Hamet, Alexandre Brun, Willy Rozenbaum, Jean-Michel Molina\",\"doi\":\"10.1097/QAD.0000000000003899\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In a retrospective study conducted in three hospitals in Paris, generic antiretroviral accounted for 30.2% of all prescriptions. Tenofovir disoproxil/emtricitabine (TDF/FTC) was the most prescribed generic ART (82.3% of generic prescriptions). Generic ART (gART) was more likely to be prescribed to women, to patients less than 50 years, and with recent HIV diagnosis less than 3 years. Physicians prescribed more gART if they were men, older than 55 years or worked at a university teaching hospital.\",\"PeriodicalId\":7502,\"journal\":{\"name\":\"AIDS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/QAD.0000000000003899\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000003899","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

在巴黎三家医院进行的一项回顾性研究中，非专利抗逆转录病毒药物占所有处方的 30.2%。替诺福韦酯/恩曲他滨（TDF/FTC）是处方量最大的非专利抗逆转录病毒疗法（占非专利处方的 82.3%）。非专利抗逆转录病毒疗法（gART）更有可能被开给女性患者、50 岁以下的患者以及最近确诊 HIV 不到 3 年的患者。如果医生是男性、年龄在 55 岁以上或在大学教学医院工作，则会开出更多的非专利抗逆转录病毒疗法处方。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France.

In a retrospective study conducted in three hospitals in Paris, generic antiretroviral accounted for 30.2% of all prescriptions. Tenofovir disoproxil/emtricitabine (TDF/FTC) was the most prescribed generic ART (82.3% of generic prescriptions). Generic ART (gART) was more likely to be prescribed to women, to patients less than 50 years, and with recent HIV diagnosis less than 3 years. Physicians prescribed more gART if they were men, older than 55 years or worked at a university teaching hospital.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

AIDS 医学-病毒学

CiteScore

5.90

自引率

5.30%

发文量

478

审稿时长

3 months

期刊介绍： Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.